logo

For the Inventor, By the Inventor

Vliermaal, Belgium

Jo Alen

This inventor holds 10 USPTO granted patents and 4 published patent applications and 8 EPO patents. Top assignees: Gruenenthal Gmbh, Grunenthal Gmbh. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jo Alen. Retrieved from https://idiyas.com/inventor/jo-alen-41gw8xj4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 10 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.1

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Vliermaal, BE (2020 - 2021)
  • Miermaal, BE (2024)

Company Filing History:

goldMedal6 out of 361 
 
Gruenenthal Gmbh
 patents
silverMedal4 out of 107 
 
Grunenthal Gmbh
 patents

Years Active: 2020-2026

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 12747240 - Substituted [1,2,4]triazolo[4,3-a]quinoxalines, dosage forms containing them, and methods of using them to treat or prevent pain and/or inflammation (2026-09-29),
2. 12540130 - Substituted pyrrolidine amides IV (2026-02-03),
3. 12522586 - Substituted pyrrolidine amines and amides VI (2026-01-13),
4. 12358907 - Substituted pyrrolidine amides III (2025-07-15),
5. 12344605 - Substituted pyrrolidine amides II (2025-07-01),
6. 12331034 - Substituted pyrrolidine amides V (2025-06-17),
7. 12110293 - Substituted triazolo quinoxaline derivatives (2024-10-08),
8. 11981677 - Further substituted triazolo quinoxaline derivatives (2024-05-14),
9. 10981918 - Further substituted triazolo quinoxaline derivatives (2021-04-20),
10. 10626106 - Substituted pyrrolidine amides I (2020-04-21),

Title: The Innovative Contributions of Jo Alen

Introduction

Jo Alen is a notable inventor based in Vliermaal, Belgium, recognized for his significant contributions to the field of medicinal chemistry. With a total of seven patents to his name, Alen has made strides in developing compounds that have the potential to impact therapeutic practices.

Latest Patents

Among his latest patents are "Substituted pyrrolidine amides III" and "Substituted pyrrolidine amides II." Both inventions relate to compounds that act as modulators of the glucocorticoid receptor. These compounds can be utilized in the treatment and/or prophylaxis of disorders that are at least partially mediated by the glucocorticoid receptor. This innovative work highlights Alen's commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Jo Alen has worked with prominent companies such as Grünenthal GmbH. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in his field.

Collaborations

Alen has collaborated with talented individuals such as Florian Jakob and Daniela Friebe. These partnerships have fostered an environment of innovation and creativity, further enhancing the impact of his work.

Conclusion

Jo Alen's contributions to the field of medicinal chemistry through his patents and collaborations demonstrate his dedication to innovation. His work continues to pave the way for advancements in treatment options for various disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…